loading
Schlusskurs vom Vortag:
$1.36
Offen:
$1.34
24-Stunden-Volumen:
2.32M
Relative Volume:
0.06
Marktkapitalisierung:
$67.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.23M
KGV:
-6.1195
EPS:
-0.2108
Netto-Cashflow:
-
1W Leistung:
-0.77%
1M Leistung:
-14.00%
6M Leistung:
+216.18%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$1.27
$1.38
1-Wochen-Bereich:
Value
$1.14
$1.38
52-Wochen-Spanne:
Value
$0.1135
$3.9099

Klotho Neurosciences Inc Stock (KLTO) Company Profile

Name
Firmenname
Klotho Neurosciences Inc
Name
Telefon
646-916-5315
Name
Adresse
1115 BROADWAY, NEW YORK
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
KLTO's Discussions on Twitter

Vergleichen Sie KLTO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
KLTO
Klotho Neurosciences Inc
1.29 47.44M 0 -4.23M 0 -0.2108
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.81 120.40B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
542.52 61.30B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.53 41.06B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
564.59 34.29B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.55 27.09B 3.81B -644.79M -669.77M -6.24

Klotho Neurosciences Inc Aktie (KLTO) Neueste Nachrichten

pulisher
02:21 AM

Is Klotho Neurosciences Inc. a good long term investmentFree Trading Psychology Coaching - Jammu Links News

02:21 AM
pulisher
Jul 18, 2025

Is Klotho Neurosciences Inc. Equity Warrant a good long term investmentBreakthrough capital growth - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Klotho Neurosciences Inc. Equity Warrant Stock Analysis and ForecastExceptional gains - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Klotho Neurosciences Inc. Equity Warrant stockExplosive capital appreciation - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Klotho Neurosciences Regains Nasdaq Compliance - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Klotho Neurosciences Inc. Equity Warrant stock priceExceptional market performance - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Klotho Neurosciences Inc. Stock Analysis and ForecastExceptional earning trajectories - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Klotho Neurosciences Inc. stockConsistently profitable trades - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Will Klotho Neurosciences Inc. stock benefit from interest rate changesFree Stock Trading Community - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Klotho Clears Nasdaq Hurdle—KLTO Stock Remains On The Big Board - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

Klotho Neurosciences regains NASDAQ compliance - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

Klotho Neurosciences Regains NASDAQ Listing Compliance. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Biotech Firm Klotho Neurosciences Overcomes NASDAQ Delisting Risk: Full Compliance Achieved - Stock Titan

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Klotho Neurosciences Inc. Equity Warrant stock price move sharplyDaily Trade Opportunity - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Klotho Neurosciences Inc. Equity Warrant stock attracts strong analyst attentionCapital Protected Stock Selections - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Klotho Neurosciences Inc. stock attracts strong analyst attentionChart Based Entries - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Klotho Neurosciences Inc. Equity Warrant stock performs during market volatilityFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Klotho Neurosciences Inc. stock performs during market volatilityLow Risk Trading Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Klotho Neurosciences Inc. stock price move sharplyFree Real-Time Trading Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

FDA Grants Orphan Status to UAB ALS Gene Therapy - Mirage News

Jul 15, 2025
pulisher
Jul 14, 2025

Klotho Neurosciences Receives FDA Orphan Drug Designation - MSN

Jul 14, 2025
pulisher
Jul 11, 2025

Stock Shift: KLTO’s Rollercoaster Week in The Markets - StocksToTrade

Jul 11, 2025
pulisher
Jul 11, 2025

Why Did Klotho Neurosciences Plunge 14.38% Despite FDA Designation? - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene Therapy - Asianet Newsable

Jul 11, 2025
pulisher
Jul 10, 2025

Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease") - The Malaysian Reserve

Jul 10, 2025
pulisher
Jul 10, 2025

Why Klotho Surged 50% Overnight? - StocksToTrade

Jul 10, 2025
pulisher
Jul 10, 2025

Klotho Stock Delivers 1,222% Biotech Blowout: Opportunity or Bubble? - Benzinga

Jul 10, 2025
pulisher
Jul 10, 2025

Klotho Neurosciences’ ALS therapy awarded FDA Orphan Drug Designation - Proactive financial news

Jul 10, 2025
pulisher
Jul 10, 2025

Klotho’s ALS candidate gains US orphan drug designation - BioWorld MedTech

Jul 10, 2025
pulisher
Jul 10, 2025

Klotho Neurosciences stock soars after FDA grants orphan drug status for ALS - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

US Stocks Likely To Open Lower A Day After Nasdaq Hits Record High: Nvidia, Kellogg, Klotho In Focus - Benzinga

Jul 10, 2025
pulisher
Jul 10, 2025

Klotho Neurosciences Receives US FDA Orphan Drug Designation for Potential ALS Drug Candidate - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

Why Did Klotho Neurosciences Stock Soar 45.99%? - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

Why Did Klotho Neurosciences Soar 16.79%? - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

FDA Breakthrough: New Gene Therapy Shows Promise for Lou Gehrig's Disease Treatment - Stock Titan

Jul 10, 2025
pulisher
Jul 07, 2025

Klotho Neurosciences Navigates Debt Reduction and NASDAQ Compliance Amid Gene Therapy Growth Potential - AInvest

Jul 07, 2025
pulisher
Jun 30, 2025

Klotho Neurosciences Surges: What’s Driving the Gains? - timothysykes.com

Jun 30, 2025
pulisher
Jun 30, 2025

Why Did Klotho Neurosciences Soar 61.11%? - AInvest

Jun 30, 2025
pulisher
Jun 30, 2025

Biotech Stock Rips Following Key Announcement - The Globe and Mail

Jun 30, 2025
pulisher
Jun 30, 2025

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS - Weekly Voice

Jun 30, 2025
pulisher
Jun 24, 2025

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population - Taiwan News

Jun 24, 2025

Finanzdaten der Klotho Neurosciences Inc-Aktie (KLTO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.88
price down icon 0.59%
$35.59
price up icon 0.34%
$102.56
price down icon 1.55%
$26.20
price down icon 5.18%
$110.02
price down icon 0.92%
biotechnology ONC
$294.55
price up icon 1.45%
Kapitalisierung:     |  Volumen (24h):